What is PT-141 / Bremelanotide being studied for?
Current source-backed research areas include Hypoactive sexual desire disorder, Melanocortin receptors, Sexual distress, Female sexual health. These areas describe investigation, not established personal benefit.
DIRECT ANSWER
PT-141 / Bremelanotide research areas.
Current source-backed research areas include Hypoactive sexual desire disorder, Melanocortin receptors, Sexual distress, Female sexual health. These areas describe investigation, not established personal benefit.
Reviewed August 8, 2026. Each statement links to its evidence record, followed by the primary and official sources used for this answer.
Hypoactive sexual desire disorder, Melanocortin receptors, Sexual distress, Female sexual health.
Open evidence recordTwo randomized phase 3 trials support branded bremelanotide for acquired, generalized HSDD in premenopausal women.
Open evidence recordMechanism and nonclinical safety were evaluated as part of product development; the clinical conclusion remains indication-specific.
Open evidence recordPRIMARY & OFFICIAL SOURCES
Sources for this answer.
3 source records, with duplicates removed.